Comparison of survival outcomes of patients with newly diagnosed glioblastoma treated with standard chemoradiation in and outside of clinical trials

被引：0
|
作者：
Rahman, Rifaquat
Youssef, Gilbert
Ventz, Steffen
Redd, Robert
McDunn, Jon
Louv, William
Alexander, Brian Michael
Wen, Patrick Y.
Trippa, Lorenzo
机构：
[1] Dana Farber Brigham & Womens Canc Ctr, Boston, MA USA
[2] Dana Farber Canc Inst, Boston, MA USA
[3] Dana Farber Canc Inst, Brookline, MA USA
[4] Project Data Sphere, Morrisville, NC USA
[5] Project Data Sphere, Cary, NC USA
[6] Dana Farber Canc Inst Brigham & Womens Hosp, Boston, MA USA
[7] Harvard Med Sch, Dana Farber Brigham & Womens Canc Ctr, Boston, MA USA
[8] Dana Farber Canc Inst, Dept Data Sci, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2051
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Correlation of Molecular Features With Clinical Outcomes in Glioblastoma Treated with Chemoradiation
    Liveringhouse, C.
    Grass, G. D.
    Ahmed, K. A.
    Naghavi, A. O.
    Macaulay, R. J.
    Etame, A. B.
    Tran, N.
    Forsyth, P.
    Sahebjam, S.
    Johnstone, P. A. S.
    Robinson, T. J.
    Yu, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E605 - E606
  • [32] Comparison of outcomes in cancer patients treated within and outside clinical trials: Conceptual framework and structured review
    Peppercorn, JM
    Weeks, JC
    Cook, EF
    Joffe, S
    LANCET, 2004, 363 (9405): : 263 - 270
  • [33] COMPARISON OF OUTCOMES IN CANCER PATIENTS TREATED WITHIN AND OUTSIDE CLINICAL TRIALS: CONCEPTUAL FRAMEWORK AND STRUCTURED VIEW
    Hafeez, Lubna
    Hafeez, Kiran
    Shahzad, Saqib
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 5 (10): : 10527 - 10532
  • [34] Correlation of response with survival endpoints in patients with newly diagnosed and recurrent glioblastoma (GBM) treated on prospective North Central Cancer Treatment Group (NCCTG) clinical trials
    Jaeckle, K. A.
    Wu, W.
    Kosel, M.
    Flynn, P. J.
    Buckner, J. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [35] Clinical prognostic factors affecting survival in patients with newly diagnosed Glioblastoma Multiforme (GBM).
    Gorlia, T
    Stupp, R
    Eisenhauer, EA
    Mirimanoff, RO
    Van Den Bent, MJ
    Belanger, K
    Lacombe, D
    Allgeier, A
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 859S - 859S
  • [36] Phase II Study of Iniparib with Concurrent Chemoradiation in Patients with Newly Diagnosed Glioblastoma
    Blakeley, Jaishri O.
    Grossman, Stuart A.
    Chi, Andrew S.
    Mikkelsen, Tom
    Rosenfeld, Myrna R.
    Ahluwalia, Manmeet S.
    Nabors, L. Burt
    Eichler, April
    Ribas, Ignacio Garcia
    Desideri, Serena
    Ye, Xiaobu
    CLINICAL CANCER RESEARCH, 2019, 25 (01) : 73 - 79
  • [37] Survival of Patients with Newly Diagnosed Glioblastoma Treated with Radiation and Temozolomide in Research Studies in the United States
    Grossman, Stuart A.
    Ye, Xiaobu
    Piantadosi, Steven
    Desideri, Serena
    Nabors, Louis B.
    Rosenfeld, Myrna
    Fisher, Joy
    CLINICAL CANCER RESEARCH, 2010, 16 (08) : 2443 - 2449
  • [38] Clinical Trial Eligibility and Outcomes in Patients With Metastatic NSCLC Treated Outside of Clinical Trials
    Oakley, Clayton K.
    Yellala, Amulya
    Tulpule, Sunil
    High, Robin
    Kishor, Apar
    Marr, Alissa S.
    ONCOLOGY-NEW YORK, 2024, 38 (12):
  • [39] Updates for newly diagnosed and recurrent glioblastoma: a review of recent clinical trials
    Fukushima, Corinna M.
    de Groot, John
    CURRENT OPINION IN NEUROLOGY, 2024, 37 (06) : 666 - 671
  • [40] Association between temporal muscle thickness and clinical outcomes in patients with newly diagnosed glioblastoma
    Geon An
    Stephen Ahn
    Jae-Sung Park
    Sin- Soo Jeun
    Yong- Kil Hong
    Journal of Cancer Research and Clinical Oncology, 2021, 147 : 901 - 909
12345